352 related articles for article (PubMed ID: 24838000)
1. Mapping pathological phenotypes in a mouse model of CDKL5 disorder.
Amendola E; Zhan Y; Mattucci C; Castroflorio E; Calcagno E; Fuchs C; Lonetti G; Silingardi D; Vyssotski AL; Farley D; Ciani E; Pizzorusso T; Giustetto M; Gross CT
PLoS One; 2014; 9(5):e91613. PubMed ID: 24838000
[TBL] [Abstract][Full Text] [Related]
2. Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder.
Fuchs C; Gennaccaro L; Trazzi S; Bastianini S; Bettini S; Lo Martire V; Ren E; Medici G; Zoccoli G; Rimondini R; Ciani E
Neural Plast; 2018; 2018():9726950. PubMed ID: 29977282
[TBL] [Abstract][Full Text] [Related]
3. CDKL5 deficiency in forebrain glutamatergic neurons results in recurrent spontaneous seizures.
Wang HT; Zhu ZA; Li YY; Lou SS; Yang G; Feng X; Xu W; Huang ZL; Cheng X; Xiong ZQ
Epilepsia; 2021 Feb; 62(2):517-528. PubMed ID: 33400301
[TBL] [Abstract][Full Text] [Related]
4. HDAC4: a key factor underlying brain developmental alterations in CDKL5 disorder.
Trazzi S; Fuchs C; Viggiano R; De Franceschi M; Valli E; Jedynak P; Hansen FK; Perini G; Rimondini R; Kurz T; Bartesaghi R; Ciani E
Hum Mol Genet; 2016 Sep; 25(18):3887-3907. PubMed ID: 27466189
[TBL] [Abstract][Full Text] [Related]
5. Molecular and Synaptic Bases of CDKL5 Disorder.
Zhu YC; Xiong ZQ
Dev Neurobiol; 2019 Jan; 79(1):8-19. PubMed ID: 30246934
[TBL] [Abstract][Full Text] [Related]
6. Key clinical features to identify girls with CDKL5 mutations.
Bahi-Buisson N; Nectoux J; Rosas-Vargas H; Milh M; Boddaert N; Girard B; Cances C; Ville D; Afenjar A; Rio M; Héron D; N'guyen Morel MA; Arzimanoglou A; Philippe C; Jonveaux P; Chelly J; Bienvenu T
Brain; 2008 Oct; 131(Pt 10):2647-61. PubMed ID: 18790821
[TBL] [Abstract][Full Text] [Related]
7. Dendritic Spine Instability in a Mouse Model of CDKL5 Disorder Is Rescued by Insulin-like Growth Factor 1.
Della Sala G; Putignano E; Chelini G; Melani R; Calcagno E; Michele Ratto G; Amendola E; Gross CT; Giustetto M; Pizzorusso T
Biol Psychiatry; 2016 Aug; 80(4):302-311. PubMed ID: 26452614
[TBL] [Abstract][Full Text] [Related]
8. Searching for biomarkers of CDKL5 disorder: early-onset visual impairment in CDKL5 mutant mice.
Mazziotti R; Lupori L; Sagona G; Gennaro M; Della Sala G; Putignano E; Pizzorusso T
Hum Mol Genet; 2017 Jun; 26(12):2290-2298. PubMed ID: 28369421
[TBL] [Abstract][Full Text] [Related]
9. Altered NMDAR signaling underlies autistic-like features in mouse models of CDKL5 deficiency disorder.
Tang S; Terzic B; Wang IJ; Sarmiento N; Sizov K; Cui Y; Takano H; Marsh ED; Zhou Z; Coulter DA
Nat Commun; 2019 Jun; 10(1):2655. PubMed ID: 31201320
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-Dependent Kinase-Like 5 (CDKL5): Possible Cellular Signalling Targets and Involvement in CDKL5 Deficiency Disorder.
Katayama S; Sueyoshi N; Inazu T; Kameshita I
Neural Plast; 2020; 2020():6970190. PubMed ID: 32587608
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic loss of cyclin-dependent kinase-like 5 recapitulates methylphenidate-remediable hyperlocomotion in mouse model of CDKL5 deficiency disorder.
Jhang CL; Lee HY; Chen JC; Liao W
Hum Mol Genet; 2020 Aug; 29(14):2408-2419. PubMed ID: 32588892
[TBL] [Abstract][Full Text] [Related]
12. Exploring genotype-phenotype relationships in the CDKL5 deficiency disorder using an international dataset.
MacKay CI; Wong K; Demarest ST; Benke TA; Downs J; Leonard H
Clin Genet; 2021 Jan; 99(1):157-165. PubMed ID: 33047306
[TBL] [Abstract][Full Text] [Related]
13. CDKL5, a novel MYCN-repressed gene, blocks cell cycle and promotes differentiation of neuronal cells.
Valli E; Trazzi S; Fuchs C; Erriquez D; Bartesaghi R; Perini G; Ciani E
Biochim Biophys Acta; 2012; 1819(11-12):1173-85. PubMed ID: 22921766
[TBL] [Abstract][Full Text] [Related]
14. Epileptic encephalopathy and atypical Rett syndrome with mutations in CDKL5: clinical and molecular characterization of two Brazilian patients.
Ermel EL; Carneiro LC; Souza CF; Crippa AC; Sanseverino MT; Raskin S
Arq Neuropsiquiatr; 2013 Jun; 71(6):414-5. PubMed ID: 23828526
[No Abstract] [Full Text] [Related]
15. Clinical evolution and epilepsy outcome in three patients with CDKL5-related developmental encephalopathy.
Bernardo P; Ferretti A; Terrone G; Santoro C; Bravaccio C; Striano S; Coppola A; Striano P
Epileptic Disord; 2019 Jun; 21(3):271-277. PubMed ID: 31225800
[TBL] [Abstract][Full Text] [Related]
16. A GABA
Gennaccaro L; Fuchs C; Loi M; Roncacè V; Trazzi S; Ait-Bali Y; Galvani G; Berardi AC; Medici G; Tassinari M; Ren E; Rimondini R; Giustetto M; Aicardi G; Ciani E
Neurobiol Dis; 2021 Jun; 153():105304. PubMed ID: 33621640
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and gene mutational spectrum of CDKL5-related diseases in a cohort of Chinese patients.
Zhao Y; Zhang X; Bao X; Zhang Q; Zhang J; Cao G; Zhang J; Li J; Wei L; Pan H; Wu X
BMC Med Genet; 2014 Feb; 15():24. PubMed ID: 24564546
[TBL] [Abstract][Full Text] [Related]
18. Site-specific abnormalities in the visual system of a mouse model of CDKL5 deficiency disorder.
Lupori L; Sagona G; Fuchs C; Mazziotti R; Stefanov A; Putignano E; Napoli D; Strettoi E; Ciani E; Pizzorusso T
Hum Mol Genet; 2019 Sep; 28(17):2851-2861. PubMed ID: 31108505
[TBL] [Abstract][Full Text] [Related]
19. X-linked cellular mosaicism underlies age-dependent occurrence of seizure-like events in mouse models of CDKL5 deficiency disorder.
Terzic B; Cui Y; Edmondson AC; Tang S; Sarmiento N; Zaitseva D; Marsh ED; Coulter DA; Zhou Z
Neurobiol Dis; 2021 Jan; 148():105176. PubMed ID: 33197557
[TBL] [Abstract][Full Text] [Related]
20. Chemical genetic identification of CDKL5 substrates reveals its role in neuronal microtubule dynamics.
Baltussen LL; Negraes PD; Silvestre M; Claxton S; Moeskops M; Christodoulou E; Flynn HR; Snijders AP; Muotri AR; Ultanir SK
EMBO J; 2018 Dec; 37(24):. PubMed ID: 30266824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
